An efflux pump deletion mutant enabling the discovery of a macrolide as an overlooked anti-P. aeruginosa active compound-Reference-Cited by-同舟云学术

An efflux pump deletion mutant enabling the discovery of a macrolide as an overlooked anti-P. aeruginosa active compound

Published:2023-03-24 Issue:5 Volume:76 Page:301-303
ISSN:0021-8820
Container-title:The Journal of Antibiotics
language:en
Short-container-title:J Antibiot

Author:

Kimishima Aoi,Sakai Kazunari,Honsho Masako,Wasuwanich Paul,Matsui Hidehito^ORCID,Watanabe Yoshihiro^ORCID,Iwatsuki Masato^ORCID,Sunazuka Toshiaki,Arima Naoaki,Abe Kazutoyo,Hanaki Hideaki,Asami Yukihiro^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology

Link

https://www.nature.com/articles/s41429-023-00607-0.pdf

Reference17 articles.

1. Murray CJL, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.

2. Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543:15.

3. Bodey GP, Bolivar R, Fainstein V, Jadeja L. Infections caused by Psudomonas aeruginosa. Rev Infect Dis. 1983;5:279–313.

4. Malhotra S, Hayes D Jr, Wozniak DJ. Cystic fibrosis and Pseudomonas aeruginosa: the host-microbe interface. Clin Microbiol Rev. 2019;32:e00138–18.

5. Stoitsova SO, Bruan Y, Ullrich MS, Weingart H. Charactarization of the RND-type multidrug efflux pump MexAB-OprM of the plant pathogen Pseudomonas syringae. Appl Environ Microbiol. 2008;74:3387–93.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efflux pump inhibitor, phenylalanine-arginine beta-naphthylamide analog potentiates the activity of 5-O-mycaminosyltylonolide for multi-drug resistant Pseudomonas aeruginosa;The Journal of Antibiotics;2024-03-11

2. A combination strategy of a semisynthetic macrolide, 5-O-mycaminosyltylonolide with polymyxin B nonapeptide for multi-drug resistance P. aeruginosa;The Journal of Antibiotics;2023-05-19

3. Overcoming Native Macrolide and Acquired Multidrug-Resistant <i>Pseudomonas aeruginosa</i> with Azithromycin and Polymyxin B Nonapeptide;BPB Reports;2023